The clinical value of fine needle biopsy in breast cancer

钟颖; 孙强; 黄汉源; 周易冬; 茅枫; 关竞红; 林燕; 徐雅莉

doi:10.3969/j.issn.1007-3969.2013.11.013

您当前的位置：

首页 >

文章列表页 >

The clinical value of fine needle biopsy in breast cancer

更新时间：2025-12-31

- The clinical value of fine needle biopsy in breast cancer
- China Oncology Vol. 23, Issue 11, Pages: 926-929(2013)
- 作者机构：
  
  中国医学科学院, 北京协和医学院, 北京协和医院乳腺外科,北京,100730
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2013.11.013
  CLC：
- Published Online：18 February 2014，
  
  Published：18 February 2013
- 稿件说明：
移动端阅览
钟颖,孙强,黄汉源,周易冬,茅枫,关竞红,林燕,徐雅莉. 乳腺癌细针穿刺活检的临床应用价值[J]. 中国癌症杂志, 2013, 23(11): 926-929.

钟颖, 孙强, 黄汉源, et al. The clinical value of fine needle biopsy in breast cancer[J]. China Oncology, 2013, 23(11): 926-929.
钟颖,孙强,黄汉源,周易冬,茅枫,关竞红,林燕,徐雅莉. 乳腺癌细针穿刺活检的临床应用价值[J]. 中国癌症杂志, 2013, 23(11): 926-929. DOI： 10.3969/j.issn.1007-3969.2013.11.013.

钟颖, 孙强, 黄汉源, et al. The clinical value of fine needle biopsy in breast cancer[J]. China Oncology, 2013, 23(11): 926-929. DOI： 10.3969/j.issn.1007-3969.2013.11.013.

摘要

背景与目的：随着乳腺癌术前诊疗手段的发展，细针穿刺似乎不再受临床医生的青睐。细针穿刺作为乳腺癌的术前诊断方法之一，其安全及有效性存在争议。本研究探讨30年来我院乳腺癌细针穿刺与复发、转移的关系。方法：统计我院1975—2006年1 260例乳腺癌患者的临床资料，根据是否术前细针穿刺分组，比较2组间临床基本特点、复发转移率、无瘤生存率。结果：细针穿刺阳性率为61.4%，其中Ⅳ期患者阳性率最高，达100%；细针穿刺组中以Ⅱ期和Ⅲ期患者居多，均为45.2%；细针穿刺组和非细针穿刺组的局部复发率(7.0% vs 6.4%)、复发转移率(13.2% vs 14.0%)、5年无瘤生存率(82.0% vs 81.0%)及10年无瘤生存率(51.0%vs 64.0%)差异均无统计学意义。结论：细针穿刺具有易操作、阳性率高、对复发及生存无影响等优点，因此对乳腺癌患者的术前诊断仍有较高的临床应用价值。

Abstract

Background and purpose: With the development of the means of preoperative diagnosis and treatment of breast cancer

fine needle puncture no longer seems to be popular with the clinical use. The safety and effectiveness of fine needle aspiration as preoperative diagnosis of breast cancer are controversial. This study was aimed to investigate the application of fine needle aspiration (FNA) of breast cancer and association between FNA and recurrence and metastasis for 30 years in our hospital. Methods: A total number of 1 260 patients with breast cancer treated in Peking Union Medical College Hospital from 1975 to 2006 were reviewed in two groups for clinical characters

recurrence

and survival rate. The two groups were FNA and non-FNA. Results: The positive rate of FNA was 61.4% and the highest rate was in Ⅳ stage (100%). Stage Ⅱ and Ⅲ were the major ones in FNA group (45.2%). The local recurrence (7.0% vs 6.4%)

recurrence and metastasis (13.2% vs 14.0%)

5-year (82.0% vs 81.0%) and 10-year disease free survival rates (51.0% vs 64.0%) have no significant difference between FNA and non-FNA groups. Conclusion: FNA is still one of the most important methods for preoperative investigation of breast cancer.

关键词

Keywords

references

Views

3554

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study

Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study

Circ-0007766 acts as a miR-1972 sponge to promote breast cancer cell migration and invasion via upregulation of HER2

Mechanism of breast cancer centrosome regulatory protein SEC23B on tumor invasion and metastasis

Study of CCL28 expression in breast cancer

Related Author

Ximei ZHANG

Yixuan ZHOU

Yan ZHAO

Xuan ZHOU

Xudong WANG

Yingbin YAN

Peiguo WANG

Sumei FAN

Related Institution

Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors

Tianjin Clinical Research Center for Malignant Tumors

Stomatological Clinical College of Tianjin Medical University

Department of Oral and Maxillofacial-Head and Neck Surgery, Tianjin Stomatological Hospital Affiliated to Nankai University School of Medicine

Tianjin Key Laboratory of Oral and Maxillofacial Functional Reconstruction

AI问答

⁰